Cargando…
A nationwide pilot study on breast cancer screening in Peru
INTRODUCTION: A high prevalence of advanced breast cancer (BC) is a common scenario in Latin America. In Peru, the frequency of BC at Stages III/IV is ≈50% despite implementation of a programme for breast cancer screening (BCS) along the country. We carried out a study to assess the feasibility and...
Autores principales: | Araujo, Jhajaira M, Gómez, Andrea C, Jongh, Winston Zingg-De, Ausejo, Jhon, Córdova, Iván, Schwarz, Luis J, Bretel, Denisse, Fajardo, Williams, Saravia-Huarca, Luis G, Barboza-Meca, Joshuan, Morante, Zaida, Guillén, Juan R, Gómez, Henry, Cárdenas, Nadezhda K, Hernández, Lady, Melo, Walter, Villarreal-Garza, Cynthia, Caglevic, Christian, Palacio, Carolina, García, Héctor, Mejía, Gerson, Flores, Claudio, Vallejos, Carlos, Pinto, Joseph A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937072/ https://www.ncbi.nlm.nih.gov/pubmed/36816782 http://dx.doi.org/10.3332/ecancer.2023.1494 |
Ejemplares similares
-
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
por: Pinto, Joseph A, et al.
Publicado: (2018) -
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
por: Pinto, Joseph A., et al.
Publicado: (2017) -
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
por: Araujo, Jhajaira M., et al.
Publicado: (2018) -
Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015
por: Rolfo, Christian, et al.
Publicado: (2016) -
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report
por: Valencia, Guillermo Arturo, et al.
Publicado: (2021)